Salesforce Unveils Life Sciences Partner Network to Accelerate Digital Labor and Data Programs
This open ecosystem of agencies and consulting partners enables Salesforce customers to choose from a variety of industry services, including:
Migration support to scale their transition from legacy CRM systems with agility
Agent-first implementations and training to seamlessly deploy and extend the Agentforce digital labor platform
Data kits and topics to activate AI agents with the industry context they need to reason and take action
Why It Matters: Life sciences organizations struggle with disparate systems and significant interoperability challenges. In fact, pharmaceutical and medical technology manufacturers use an average of 78 different systems, with the health industry generating an estimated 36% of all the world's data, 90% of which is unstructured. Amid regulatory constraints, resource shortages, and cybersecurity risks, digital labor in the form of AI agents offers a solution to expand capacity, but requires reliable data from multiple sources as well as skilled implementation.
What's New: The life sciences partner network will work in tandem with Salesforce's Professional Services and Customer Success teams to enable pharma and medtech organizations to harmonize all their data. Regardless of where it resides, Life Sciences Cloud can activate this data to power intelligent, personalized experiences for healthcare professionals and patients while working hand-in-hand with an extended digital workforce to realize value faster. Services include:
Migration Alliance
A coalition of worldwide agencies and consulting partners, along with migration framework technologies and solutions from Salesforce and its partners, will guide customers through a seamless transition from legacy platforms to Life Sciences Cloud while maintaining backward compatibility. This group includes Accentu r e, Avenga, BASE life science, Capgemini, Coastal, Cognizant, Deloitte, Epista Life Science, Infosys, Mavens, a Komodo Health Company, KPMG, Me r kle, Publicis Sapient & Publicis Health, PwC, Slalom, To rr ent, Wilco Source, a CitiusTech Company, and ZS.
These partners will use their extensive therapeutic development, care delivery, and technological domain to tailor the purpose-built solution to each organization's unique needs. This commitment includes significant investments in Salesforce training and certifications, jointly developed tools for reusable data mapping and migration, and industry implementation experience and change management.
Agent-First Implementations
With deep intellectual capital and global expertise, this consulting network — which includes Migration Alliance partners as well as Bain, Boston Consulting Group (BCG), and McKinsey & Company — will help ensure solutions are finely tuned to address industry-specific challenges. Salesforce is also partnering with LPW Training Services, a leading provider of learning solutions for healthcare and life sciences, to streamline onboarding and accelerate user adoption of Life Sciences Cloud to maximize ROI. With tailored Agentforce implementation services focused on aligning intelligent technology with strategic objectives, these partners will help drive scalability and performance gains for pharmaceutical and medical technology companies by:
Streamlining testing and reducing deployment time to lower costs and quickly resolve configuration issues
Promoting adoption with end user training to maximize investment and enrich the user experience
Deploying AI agents that enhance efficiency, automate workflows, and deliver actionable insights
Prebuilt Agent Skills, Data Connectors, and Applications
Using MuleSoft and Data Cloud, partners will unlock access to industry data through seamless integration with Life Sciences Cloud to provide a 360-degree view of patients, HCPs, and partners. Leveraging the Einstein Trust Layer with bidirectional, zero copy exchange and ready-to-use applications, these act as an extension of the platform and help establish a foundation for secure and trusted AI.
athenahealth APIs will enable customers to seamlessly exchange data between Salesforce and its EHR to enable real-time prior authorizations, care management, appointment scheduling, medical history, and medication refills.
Box's Intelligent Content Management integration with Life Sciences Cloud enables Commercial and R&D teams to securely collaborate, review, and e-sign critical promotional, clinical, and contract documents within Box's GxP-compliant content layer — without leaving Salesforce.
ComplianceQuest supports compliance for clinical trials, adverse event reporting, and manufacturing and will allow Agentforce to automate adverse event triage to promote timely reporting and resolution, and identify recurring risks across trial sites to prioritize mitigation efforts. Agentforce can also flag nonconformances in the manufacturing of clinical trial supplies, helping to safeguard product quality.
Definitive Healthcare allows sales teams to get real-time access to fast insights to prepare for strategic conversations, build precise market segmentations, and craft targeted communications, right within their Salesforce environment. Users can leverage comprehensive facility-level data — including financials, clinical metrics, referral patterns, affiliations, and population health trends.
Honeywell's TrackWise Quality helps shift from reactive to proactive quality management. With enhanced tracking, analytics, and AI capabilities across quality processes, the solution suite enables life science companies to better leverage data to enhance performance and make decision-making more effective and efficient. The new Agentforce actions will focus on improving and streamlining quality issue resolution with advanced AI solutions related to chat assistance, workflow automation, and complaint intake.
H1 will fuel Life Sciences Cloud with comprehensive HCP profiles aggregating publications, clinical trials, congress activity, payments, social media, organizational hierarchies, patient demographics, and medical and prescription claims to enhance HCP and Key Opinion Leaders (KOLs) identification and engagement across all touchpoints.
Infinitus.ai 's integration with Life Sciences Cloud allows Agentforce to verify pharmacy or durable medical equipment (DME) eligibility by checking directly with electronic providers to validate insurance coverage, calculate copays, and collect any missing information, helping to prevent delays to treatment.
S2N Health's RepSignal embeds expert-curated customer intelligence in the flow of work for sales, marketing, and commercial leadership. Comprehensive RepSignal data, including procedure and diagnosis volumes, referrals, Sunshine Act information, research activities, and facility metrics, deeply integrated with Life Sciences Cloud and Agentforce skills such as Pre-Visit Summary, seamlessly equips medtech teams with key insights to precisely target, engage, and convert high-value customers.
Viz.ai 's AI-powered care coordination solution leverages AI agents for real-time patient activation and HCP engagement to accelerate time to treatment, optimize sales and marketing effectiveness, and drive high-impact launches resulting in better patient outcomes.
Vodori's AppExchange solution will accelerate the compliant review and approval of medical, legal, and regulatory (MLR) content, with automated publishing of approved assets directly into Life Sciences Cloud. This ensures MSLs and field teams can access the latest educational and promotional materials — seamlessly, compliantly, and in real time.
The Salesforce Perspective:
'We are in an unprecedented market moment where, with digital labor grounded in rich data, international life sciences organizations have the opportunity to completely reimagine the way they interact with patients and HCPs. Backed by over two decades of industry expertise, Salesforce is uniquely equipped to pioneer this next era with our deeply unified Platform that brings together apps, data, life sciences-specific workflows, and AI – all wrapped in trust and compliance. Together with our open ecosystem of partners, we'll help scale the delivery of connected, agent-first experiences and outcomes, from clinical through commercial.'
– Frank Defesche, Senior Vice President and General Manager, Salesforce Life Sciences
Availability:
Customers have access to Salesforce's Professional Services, Customer Success, Migration Alliance, and Implementation Partners today.
LPW Training Services is available starting today.
ISV apps, connectors, and Agentforce actions, including Box, Compliance Quest, RepSignal, and TrackWise Digital are available today on the AppExchange and AgentExchange.
Vodori integration will be available later this month on the AppExchange.
New Definitive, H1, and Viz.ai integrations will be available in late 2025.
Infinitus.ai integration is available today via MuleSoft. Additional clearinghouse and EHR integrations like athenahealth will be available starting in June 2025.
Learn More:
Any unreleased services or features referenced here are not currently available and may not be delivered on time or at all. Customers should make their purchase decisions based upon features that are currently available.
About Salesforce
Salesforce helps organizations of any size reimagine their business with AI. Agentforce — the first digital labor solution for enterprises — seamlessly integrates with Customer 360 applications, Data Cloud, and Einstein AI to create a limitless workforce, bringing humans and agents together to deliver customer success on a single, trusted platform. Visit www.salesforce.com for more information.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
How To Earn $500 A Month From Home Depot Stock Ahead Of Q2 Earnings
The Home Depot, Inc. (NYSE:HD) will release earnings results for the second quarter, before the opening bell on Tuesday, Aug. 19. Analysts expect the home improvement retailer to report quarterly earnings at $4.69 per share, up from $4.60 per share in the year-ago period. Home Depot projects to report quarterly revenue of $45.31 billion. Compare that to the $43.17 billion it generated last year during the second quarter, according to data from Benzinga Pro. With the recent buzz around Home Depot, some investors may be eyeing potential gains from the company's dividends. Currently, it offers an annual dividend yield of 2.30%, which is a quarterly dividend amount of $2.30 per share ($9.20 a year). So, how can investors capitalize on its dividend yield to earn a regular $500 monthly? To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $260,396 or around 652 shares. For a more modest $100 per month or $1,200 per year, you would need $51,919 or around 130 shares. To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($9.20 in this case). So, $6,000 / $9.20 = 652 ($500 per month), and $1,200 / $9.20 = 130 shares ($100 per month). Note that the dividend yield can change on a rolling basis, as both the dividend payment and the stock price fluctuate over time. View more earnings on HD How that works: The dividend yield is computed by dividing the annual dividend payment by the stock's current price. For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40). Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price remains unchanged. Conversely, if the dividend payment decreases, so will the yield. HD Price Action: Shares of Home Depot fell 0.2% to close at $399.38 on Friday. On Wednesday, Truist Securities analyst Scot Ciccarelli maintained Home Depot with a Buy and raised the price target from $417 to $433, while Telsey Advisory Group analyst Joseph Feldman maintained the stock with an Outperform rating and maintained a $455 price More: Image: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? HOME DEPOT (HD): Free Stock Analysis Report This article How To Earn $500 A Month From Home Depot Stock Ahead Of Q2 Earnings originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
Cohesys Announces First-in-Human Use of Investigational BoneTape™ in Craniofacial Fracture Repair
TORONTO, August 18, 2025--(BUSINESS WIRE)--Cohesys Inc., a Toronto-based medical device developer of resorbable fixation technologies, today announced that the first participants have undergone treatment with BoneTape™, an investigational device designed for the fixation of non-load-bearing craniofacial fractures. The procedures were completed as planned and mark the first clinical use of this drill- and screw-free fixation system. "Reaching this milestone is significant for Cohesys as we evaluate BoneTape's potential to offer a simpler, patient-friendly approach to fracture repair," said Dr. Michael Floros, CEO of Cohesys. "The data from this study will inform our regulatory strategy and commercialization pathway." "This marks an exciting step forward for the study, and it's a privilege to be part of an effort exploring new techniques in facial-fracture treatment," said Dr. Jeffrey A. Fialkov, MD, MSc, FRCSC, Head of the Division of Plastic and Reconstructive Surgery at Sunnybrook Health Sciences Centre, Associate Professor in the Department of Surgery at the University of Toronto, and Principal Investigator for the study. "BoneTape's hardware-free approach is intended to simplify surgery and may improve the recovery experience for patients." Device- and procedure-related risks—including infection, non-union, and re-operation—will be actively monitored throughout the study's follow-up period. Dr. Janaina Bortolatto, VP, Clinical Operations for Cohesys noted, "The completion of these first cases with BoneTape reflects the dedication of our team and our clinical partners. We are focused on gathering the clinical data needed to evaluate BoneTape for potential future use." BoneTape is applied with a handheld applicator that affixes the resorbable fixation device to bone surfaces without drilling or screws. The study will determine whether this design performs as intended, potentially sparing patients from device-related complications and the need for hardware-removal procedures. About CohesysCohesys Inc. develops advanced resorbable fixation solutions aimed at simplifying surgery and improving bone healing. BoneTape, the company's primary technology, is currently under clinical investigation. For more information, visit BoneTape™ is a trademark of Cohesys Inc. Regulatory StatusBoneTape is an investigational device; it is not licensed for commercial sale. Its use in this clinical study has been authorized by Health Canada under an Investigational Testing Authorization (ITA). Safety and effectiveness have not been established. Identifier: NCT06600854 View source version on Contacts Company Contact: info@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
12 minutes ago
- Yahoo
NOW Insurance Ranks No. 30 In Insurance on the 2025 Inc. 5000 List
NEW YORK, August 18, 2025--(BUSINESS WIRE)--Inc. revealed today that NOW Insurance is one of the fastest growing companies in America, making the Inc. 5000 list for the second consecutive year. The company achieved the 30th spot in insurance industry rankings. The list provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment—its independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia. "Making the Inc. 5000 list for the second time is a proud milestone for NOW Insurance and a testament to the hard work, innovation, and customer-first focus of our team," said Philip Cabaud, CEO of NOW Insurance. "This recognition reflects not only our rapid growth, but also our commitment to transforming the insurance experience with modern, accessible, and transparent solutions for our clients." This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years. For the full list, company profiles, and a searchable database by industry and location, visit: "Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision," says Mike Hofman, editor-in-chief of Inc. "These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn't just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy." About NOW Insurance NOW Insurance, a data-driven, AI-powered Insurtech, is designed to disrupt a centuries-old business model to deliver a range of customizable, affordable, and flexible coverage options that meet the needs and requirements of modern healthcare providers. By leveraging advanced, next generation technologies such as predictive analytics and machine learning, NOW Insurance has transformed previously intricate and complex insurance processes into seamless, frictionless customer experiences. NOW Insurance was founded in 2019 by industry veteran Philip Cabaud to provide a best-in-class service for healthcare professionals in ways they have yet to experience with traditional, legacy insurers. For more information, please visit More about Inc. and the Inc. 5000 Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit View source version on Contacts Eileen Sullivanesullivan@
